Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Benefit finding in response to BRCA1/2 testing.

Low CA, Bower JE, Kwan L, Seldon J.

Ann Behav Med. 2008 Feb;35(1):61-9. doi: 10.1007/s12160-007-9004-9. Epub 2008 Feb 15.

PMID:
18347905
2.
3.

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.

Nelson HD, Huffman LH, Fu R, Harris EL; U.S. Preventive Services Task Force.

Ann Intern Med. 2005 Sep 6;143(5):362-79. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547.

PMID:
16144895
4.

Psychological adjustment among male partners in response to women's breast/ovarian cancer risk: a theoretical review of the literature.

Sherman KA, Kasparian NA, Mireskandari S.

Psychooncology. 2010 Jan;19(1):1-11. doi: 10.1002/pon.1582. Review.

PMID:
19472298
5.

Psychosocial aspects of genetic counseling and testing.

Vadaparampil ST, Wey JP, Kinney AY.

Semin Oncol Nurs. 2004 Aug;20(3):186-95. Review.

PMID:
15491028
6.

Psychosocial and behavioral impact of genetic counseling and testing.

Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB.

Breast Dis. 2006-2007;27:97-108. Review.

PMID:
17917142
7.

[Cognitive, emotional and behavioral impact of an uncertain outcome after study of BRCA1/2: review of the literature].

Leblond D, Brédart A, Dolbeault S, De Pauw A, Stoppa Lyonnet D, Flahault C, Sultan S.

Bull Cancer. 2011 Feb;98(2):184-98. doi: 10.1684/bdc.2011.1309. Review. French.

9.
10.

BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses.

Brunsvold AN, Wung SF, Merkle CJ.

J Am Acad Nurse Pract. 2005 Dec;17(12):518-26. Review.

PMID:
16293160
11.

A literature review of the psychological impact of genetic testing on breast cancer patients.

Schlich-Bakker KJ, ten Kroode HF, Ausems MG.

Patient Educ Couns. 2006 Jul;62(1):13-20. Epub 2005 Oct 19. Review.

PMID:
16242293
12.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
13.

Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.

Forman AD, Hall MJ.

Breast J. 2009 Sep-Oct;15 Suppl 1:S56-62. doi: 10.1111/j.1524-4741.2009.00798.x. Review.

PMID:
19775331
14.

Hereditary ovarian cancer--assessing risk and prevention strategies.

Pavelka JC, Li AJ, Karlan BY.

Obstet Gynecol Clin North Am. 2007 Dec;34(4):651-65, vii-viii. Review.

PMID:
18061862
15.

Informed consent for BRCA1 and BRCA2 testing.

Rimer BK, Sugarman J, Winer E, Bluman LG, Lerman C.

Breast Dis. 1998 Apr;10(1-2):99-114. Review.

PMID:
15687553
16.

Life after BRCA1/2 testing: family communication and support issues.

DeMarco TA, McKinnon WC.

Breast Dis. 2006-2007;27:127-36. Review.

PMID:
17917144
17.

Strategies for ovarian cancer prevention.

Dann RB, Kelley JL, Zorn KK.

Obstet Gynecol Clin North Am. 2007 Dec;34(4):667-86, viii. Review.

PMID:
18061863
18.

Psycho-social aspects of breast cancer susceptibility testing: a literature review.

Brédart A, Autier P, Audisio RA, Geragthy J.

Eur J Cancer Care (Engl). 1998 Sep;7(3):174-80. Review.

PMID:
9793009
19.

Genetic testing for inherited breast cancer risk in African Americans.

Halbert CH, Kessler LJ, Mitchell E.

Cancer Invest. 2005;23(4):285-95. Review.

PMID:
16100940
20.

Supplemental Content

Support Center